About
Technology
Issues
FAQ
Links
Official Page
TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.